Oncology
Recent findings illuminate research in oncology
Published in Hepatitis Weekly, March 21st, 2005
Study 1: Lamivudine prevents hepatitis B reactivation during breast cancer therapy.
According to recent research published in the journal Breast Cancer Research and Treatment, "in parts of Asia, about 10% of the population have chronic hepatitis B virus (HBV) infection, and cancer patients who are HBV carriers are frequently complicated by HBV reactivation while receiving cytotoxic chemotherapy."
"The condition may result in varying degrees of liver damage, causing disruption in chemotherapy and compromising the patients'...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-03-21)
More Articles from Hepatitis Weekly
- Blood Safety
Patients accidentally infected with hepatitis C respond well to interferon - Chronic Hepatitis C
Preliminary liver biopsies predict HCV-related liver fibrosis progression - Drug Resistance
Adefovir dipivoxil tackles all patterns of lamivudine-resistant hepatitis B - Food Safety
High hydrostatic pressure inactivates hepatitis A infection in oysters - Liver Transplantation
Adult living donor liver grafts offer a viable option to transplant candidates - Allergy and Immunology
CXCR6 recruits CD8 cells to the liver in graft vs. host disease - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
